𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Withdrawal of lamivudine in HBeAg-positive chronic hepatitis B patients after achieving effective maintained virological suppression

✍ Scribed by Chau-Ting Yeh; Chao-Wei Hsu; Yi-Cheng Chen; Yun-Fan Liaw

Book ID
116631594
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
160 KB
Volume
45
Category
Article
ISSN
1386-6532

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Lamivudine maintenance beyond one year a
Lamivudine maintenance beyond one year after HBeAg seroconversion is a major factor for sustained virologic response in HBeAg-positive chronic hepatitis B
✍ Hyun Woong Lee; Heon Ju Lee; Jae Seok Hwang; Joo Hyun Sohn; Jae Young Jang; Ki J πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 283 KB πŸ‘ 1 views

The reported durability of virologic response after successful lamivudine monotherapy is variable, and the question remains as to whether virologic responses can be maintained over an extended follow-up period. The aim of this study was to investigate posttreatment durability, the optimal duration o

Comparison of interferon and lamivudine
Comparison of interferon and lamivudine treatment in Japanese patients with HBeAg positive chronic hepatitis B
✍ Yasuji Arase; Kenji Ikeda; Fumitaka Suzuki; Yoshiyuki Suzuki; Masahiro Kobayashi πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 117 KB πŸ‘ 1 views

## Abstract The aim of this study was to elucidate the long‐term outcome after interferon (IFN) or lamivudine (LMV) treatment in Japanese patients with hepatitis B e antigen (HBeAg) positive chronic hepatitis B. Inclusion criteria were biopsy proven chronic hepatitis or liver cirrhosis, no history